We are live on ! Find out more
AEON.WS

AEON Biopharma Inc
AEON.WS

Delisted

AEON.WS was delisted on the 26th of April, 2024.

Back to rankings

55 hedge funds and large institutions have $8.42M invested in AEON Biopharma Inc in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 5 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 2

15% more funds holding

Funds holding: 48 → 55 (+7)

7% more capital invested

Capital invested by funds: $7.84M → $8.42M (+$576K)

0% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 5

Holders
55
Holders Change
+7
Holders Change %
+14.58%
% of All Funds
0.85%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
5
Reduced
5
Closed
2
Calls
$1.1M
Puts
–
Net Calls
+$1.1M
Net Calls Change
+$38K

Top Buyers

Rank Fund Capital Flow
1
Parallax Volatility Advisers
Parallax Volatility Advisers
California
+$127K
2
KC
Kepos Capital
New York
+$85.1K
3
QGA
Q Global Advisors
Texas
+$73.7K
4
WA
Whitebox Advisors
Minnesota
+$55.3K
5
PC
Periscope Capital
Ontario, Canada
+$47.2K

Top Sellers

Rank Fund Capital Flow
1
PAMP
Polar Asset Management Partners
Ontario, Canada
-$62.7K
2
CL
CSS LLC
Illinois
-$46.8K
3
CAC
Cowen and Company
New York
-$12K
4
Citadel Advisors
Citadel Advisors
Florida
-$11.6K
5
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT)
United Kingdom
-$2K
Name Holding Trade Value Shares
Change 		Change in
Stake
ACA
26
Arena Capital Advisors
California
$42K – – –
SCC
27
Spring Creek Capital
Kansas
$42K – – –
Goldman Sachs
28
Goldman Sachs
New York
$40K – – –
CF
29
Cantor Fitzgerald
New York
$39K +$42.4K +76,741 New
RA
30
Ramius Advisors
New York
$35K +$31.2K +56,479 +455%
ICMH
31
Integrity Capital Management (HK)
Hong Kong
$35K +$38.4K +69,514 New
Balyasny Asset Management
32
Balyasny Asset Management
Illinois
$34K – – –
GPCM
33
Granite Point Capital Management
Massachusetts
$34K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$29K – – –
SC
35
Sculptor Capital
New York
$26K – – –
AR
36
Advisory Research
Illinois
$26K +$774 +1,400 +3%
WAM
37
Wolverine Asset Management
Illinois
$25K -$553 -1,000 -2%
DCM
38
Dupont Capital Management
Delaware
$25K – – –
FCM
39
Farallon Capital Management
California
$25K – – –
FIG
40
Fortress Investment Group
New York
$25K – – –
PAMP
41
Polar Asset Management Partners
Ontario, Canada
$19K -$62.7K -113,552 -76%
CL
42
CSS LLC
Illinois
$18K -$46.8K -84,718 -71%
D.E. Shaw & Co
43
D.E. Shaw & Co
New York
$17K – – –
ESCM
44
Echo Street Capital Management
New York
$17K – – –
MCM
45
Moore Capital Management
New York
$17K – – –
EH
46
EMG Holdings
Connecticut
$13K +$13.8K +24,999 New
OMC
47
Old Mission Capital
Illinois
$9K +$9.47K +17,141 New
NAM
48
Nexpoint Asset Management
Texas
$7K – – –
RCM
49
Rivernorth Capital Management
Florida
$7K – – –
TCM
50
Tegean Capital Management
New York
$7K +$7.74K +14,000 New
1
2
3

AEON.WS Hedge Fund Activity: Q4 2021 in Review

55 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in AEON Biopharma Inc (AEON.WS) for Q4 2021, worth a combined $8.42M — up 7.3% from $7.84M a quarter earlier.

Buyers outnumbered sellers: 9 funds opened new AEON.WS positions and 2 closed out — a net gain of 7 holders — while 5 added to existing stakes and 5 trimmed.

The largest buyer was Parallax Volatility Advisers, adding an estimated $127K. The largest seller was Polar Asset Management Partners, cutting an estimated $62.7K.

  • 55 institutional investors held AEON Biopharma Inc (AEON.WS) as of Q4 2021, up from 48 in Q3 2021.
  • Funds reported $8.42M of AEON Biopharma Inc stock for Q4 2021, up 7.3% quarter-over-quarter.
  • 9 funds opened new AEON Biopharma Inc positions in Q4 2021 and 2 closed out, a net change of +7 holders.
  • The largest AEON Biopharma Inc buyer in Q4 2021 was Parallax Volatility Advisers, an estimated $127K added.
  • The largest AEON Biopharma Inc seller in Q4 2021 was Polar Asset Management Partners, an estimated $62.7K sold.

Based on aggregated 13F filings for Q4 2021.